XML 41 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Income Taxes  
Schedule of Gross Deferred Tax Asset and Related Valuation Allowance

 

 

 

 

 

 

 

 

 

    

2018

    

2017

 

Deferred tax assets:

 

 

 

 

 

 

 

Net operating loss carryforward

 

$

41,687,577

 

$

30,813,509

 

Capitalized start-up costs

 

 

1,501,895

 

 

1,695,688

 

Patent amortization

 

 

119,888

 

 

135,358

 

Research and orphan drug credits

 

 

28,123,082

 

 

21,293,509

 

Deferred rent

 

 

51,400

 

 

71,938

 

Deferred compensation

 

 

3,293,221

 

 

2,274,885

 

Other

 

 

95,564

 

 

69,906

 

Total gross deferred tax assets

 

 

74,872,627

 

 

56,354,793

 

Valuation allowance

 

 

(74,872,627)

 

 

(56,354,793)

 

Deferred tax assets

 

 

 —

 

 

 —

 

Deferred tax liabilities:

 

 

 

 

 

 

 

Total deferred tax liabilities

 

 

 —

 

 

 —

 

Net deferred tax assets

 

$

 —

 

$

 —

 

 

Schedule of Reconciliations Between Statutory Federal Income Tax Rate and Effective Income Tax Rate of Income Tax Expense

 

 

 

 

 

 

 

 

 

    

2018

    

2017

    

2016

 

U.S. Federal statutory tax rate

 

21.0

%  

34.0

%  

34.0

%

State taxes

 

5.7

 

4.4

 

4.6

 

Research credit

 

0.8

 

1.3

 

1.0

 

Orphan drug credit

 

10.4

 

11.5

 

9.0

 

Other

 

0.6

 

0.3

 

 —

 

Stock-based compensation

 

(0.1)

 

(0.7)

 

(0.7)

 

Change in valuation allowance

 

(38.4)

 

(5.1)

 

(47.9)

 

Effective change due to corporate tax rate reduction

 

 —

 

(45.7)

 

 —

 

Provision for income taxes

 

 —

%

 —

%

 —

%